Springbok Prop Asenathi Ntlabakanye Handed 18-Month Ban for Doping Violation
On Thursday, the news broke that Springbok prop Asenathi Ntlabakanye had been slapped with an 18-month ban by the Independent Doping Hearing Panel (IDHP) after being found guilty of a doping violation.
The ban came after a two-day hearing in March, with closing arguments concluded on 21 April 2026. The IDHP deliberated on the severity of the violation, the degree of fault, and the suitable sanction.
Under the strict liability framework, the panel reduced the potential maximum four-year ban to 18 months, taking into account mitigating circumstances, including a medical prescription and transparent self-declaration.
The South African Institute for Drug-Free Sport (SAIDS) stated that Ntlabakanye’s urine sample tested positive for the Hormone and Metabolic Modulator, Anastrozole, during an out-of-competition test on 22 May 2025.
The substance is classified as a ‘specified substance’ and does not warrant a mandatory suspension.
Ntlabakanye also self-declared the use of a prohibited anabolic steroid, DHEA.
He was formally charged on 9 September 2025 for the presence and use of Anastrozole and the use of DHEA.
UK Publication Takes Aim at South African Rugby
In a follow-up that many might find distasteful, UK publication The Telegraph reposted an old article alleging that South African rugby, and by extension the Springboks, have the “highest number of convicted dopers in rugby, yet a sixfold decrease in testing coincided with the 2019 and 2023 (World Cup) triumphs”.
The article referenced recent doping cases linked to Springboks, including Asenathi Ntlabakanye, Elton Jantjies, Sbu Nkosi, and Aphiwe Dyantyi, suggesting that this is just the tip of the iceberg.
It implied a major issue with both failed tests and a lack of testing for South African players.
The repost from The Telegraph seemed a clear tactic to fire shots at the Springboks on the back of Ntlabakanye’s ban, as it is unusual to repost an old story on social media.
Details of the Ban and Charges
Anastrozole appeared in the random test, while the more severe non-specified substance, DHEA, did not show up in the blood/urine analysis, likely because it had cleared Ntlabakanye’s system.
However, because Ntlabakanye honestly declared its use on his doping control form, it fell under the “strict liability” rule, triggering the charge.
The 18-month duration reflects the panel’s acknowledgment that Ntlabakanye acted in good faith on professional medical advice, avoiding the maximum four-year ban, while still holding him accountable under global anti-doping regulations.
